What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...
Read More
Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a...
Read More
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health...
Read More
How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice...
Read More
For our Global Whispers webinar in October, Clare Foy (Director – Global Market Access, Mtech Access) spoke to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and...
Read More
On Wednesday 16th August Calum Jones (Senior Consultant – Health Economics, Mtech Access) spoke to Dr George Magrath (CEO, Lexitas) about the use of AI in clinical trials, where and...
Read More
In this webinar, we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President &...
Read More
In the second episode of our Global Whispers webinar series, we explored market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) spoke to Shefali Shah...
Read More
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
